The Must-Attend Conference for Diagnostic Advancements

We are proud to host Cambridge Healthtech Institute's Fifteenth Annual Next Generation Dx Summit which will take place in-person at the Grand Hyatt Washington, D.C. on August 21-23, 2023. The Next Generation Dx Summit is the nexus for key opinion leaders across the world to share recent progress in diagnostic advancement and technology innovation. The event provides a valuable window on how point-of-care, decentralized testing, infectious disease, liquid biopsy and companion diagnostics are changing the standard of care. Now in its fifteenth year, the Next Generation Dx Summit is a must-attend event with complete coverage of the most timely and important topics for the industry. This event will livestream online for those who can't attend in-person.

Read on www.nextgenerationdx.com

The National Cancer Institute’s website explains targeted therapies as a type of cancer treatment that targets proteins that control how cancer cells grow, divide, and spread. It is the foundation of precision medicine. As researchers learn more about the DNA changes and proteins that drive cancer, they are better able to design treatments that target these proteins. The purpose of this webinar is to provide an overview of current research of targeted therapies as demonstrated by the efforts of Endeavor Biomedicines and Elevate Oncology.

Read on xtalks.com

Following the success over the past 6 year of our annual Nordic Precision Medicine Forum we are excited to announce that in 2023 we have a new venue and TWO NEW EVENTS. This allows us to convene a broader group of experts, from more disciplines, across all of the key stakeholders, in one place. As Precision Medicine initiatives around the world gather pace, the Nordic countries are in an enviable position when it comes to joining all the dots. The link between digital health, omics technologies, artificial intelligence and data means that yet more collaboration is required to ensure the success of precision medicine. As demonstrated by organisations such as SciLifeLab, the collaborative efforts of healthcare, research, industry and patient organisations is really starting to bear fruit.

Read on precisionmedicineforum.com

Join thousands of international thought leaders to discuss the latest research, technologies, innovation and business models in implementing precision medicine, biomarkers and companion diagnostics, genomic medicine, and precision health; innovation and market access strategies for at-home diagnostics, point-of-care testing and molecular diagnostics for infectious diseases; liquid biopsy and advanced diagnostics for precision oncology, including Multi-Cancer Early Detection and Minimal Residual Disease testing; and emerging technologies for spatial biology and single-cell multiomics.

Read on 10times.com

Diagnosing heart disease in its early stages is crucial, though can be a challenge. The inability to provide patients a timely diagnosis puts them at a much greater risk of serious complications and damage to the heart. To tackle this and advance treatments, healthcare organizations are turning to precision medicine.  Combining genetics, epigenetics, and artificial intelligence which looks at how environmental influences affect gene expression gives healthcare providers a much deeper look into a patient's condition and provides a pathway to treat patients more effectively, saving time and lowering costs. Join this webinar where experts will share more on how precision medicine improves the overall patient experience, provides more accurate diagnoses and can curb the incidence of heart disease nationwide.

A neoteric breakthrough in Precision Medicine has been acclaimed as the steppingstone in disease prediction and prevention strategies. This integral change in our approach to medication therapy has federal efforts in developing the ‘’Hyperindividualised’’ therapy while taking into account the genetic patterns, drug responses, lifestyle and cultural environment. The substantial research in disease treatment strategies have contributed to developing target drugs, study of novel biomarkers in disease diagnosis, regenerative medicine leading to customized therapeutic approaches. Precision Medicine will not only have an impact on targeted treatment delivery but the prospect of studying the biological complexity of disorders associated with high mortality rate and cost-efficient treatment plans.

MarketsandMarkets is delighted to announce its Precision Medicine Conference scheduled to be held on 8th - 9th February 2023 in San Diego, USA. The conference will assimilate diverse sessions on Comprehensive Overview of Precision Medicine, Novel horizons in biomarker strategies, Current Multi Omics analysis, Artificial Intelligence and Machine Learning, Gene expression Profiling in Precision Medicine, Contributions of Tissue engineering and Regenerative Medicine in target drug discovery. The event encompasses networking sessions, panel discussions, solutions, and services catering to precision medicine. The conference will constellate a full spectrum of experts, leaders, and stakeholders to share a board prospective the novel research and development in Precision Medicine. 

Read on events.marketsandmarkets.com

The Personalized medicine will enlighten the world with recent advances in personalized medicine and Novel research and inculcate new ideas about Novel health. Moreover, this personalized medicine Conferences provides the participants a great networking with peers. Internationally prominent speakers, the novel techniques, and the modern updates in the personalized medicine. Fields are the unique attributes of this conference. Personalized medicine symposiums and Workshops provide a dedicated forum for the advancement, execution and exchange of information about personalized medicine and Novel Therapies. Personalized Medicine 2022 anticipates participants around the globe with thought-provoking Keynote lectures, Oral, Young Researcher Forum and Poster presentations with Exhibition. The attending delegates include Editorial Board Members of related Journals.

Read on personalizedmedicine.pharmaceuticalconferences.com

The 6th Annual Precision Medicine Through Plasma: Using Liquid Biopsies in Contemporary Oncology Care will focus on the use of liquid biopsy in cancer, covering the latest updates on the use of these techniques across various malignancies. In general, liquid biopsy refers to sampling from the peripheral blood and other compartments in the body, isolating circulating tumor cells, cell-free DNA, and other materials to perform noninvasive genetic testing that may inform treatment decision-making. Understanding the applications of these technologies, as well as the data informing their use, is critical for practicing oncologists. 

Read on event.gotoper.com

Precision medicine is deeply transforming healthcare by tailoring care precisely to the individual. This exacting approach to care is leveraging data, genomics, and increasing interoperability to help clinicians identify the most appropriate, cost-effective treatments, and even spot previously undetected causes of disease. The aim of the “Precision Medicine Webinar” is to gather senior level executives from pharmaceutical and biotechnology companies and discuss during this full-day conference the current trends and challenges in the precision medicine industry.

Read on ubiqwebinars.com

The Personalized medicine will enlighten the world with recent advances in personalized medicine and Novel research and inculcate new ideas about Novel health. Moreover, this personalized medicine Conferences provides the participants a great networking with peers. Internationally prominent speakers, the novel techniques, and the modern updates in the personalized medicine. Fields are the unique attributes of this conference. Personalized medicine symposiums and Workshops provide a dedicated forum for the advancement, execution and exchange of information about personalized medicine and Novel Therapies.

Read on personalized-medicine.conferenceseries.com

As AGBT Precision Health enters our 6th year we continue to focus on technologies, implementation, and major research breakthroughs. This event is for leading genomic researchers, healthcare professionals, and healthcare industry stakeholders. We bring together practitioners and innovators at the interface of genomics, medicine, and health to usher in a new era of precision medicine. Our aim is to pass the torch from pioneering researchers and developers of genome technologies to first movers in healthcare who are establishing standards of care and cutting-edge applications for genome technology in everyday clinical practice.

Read on agbt.org

INVEST PharmaTech is a virtual executive summit where established biopharma companies gather with health tech and digital health innovators to transform the industry. PharmaTech is the next chapter of the biopharma industry as it aims to leverage digital innovations for a transformation that will take them to achieve even more success in the future and transform the lives of patients.

MedCity INVEST PharmaTech will bring together regional and national stakeholders across established biotech and pharma companies and link them with health tech and digital health innovators virtually to enable conversations around AI and drug discovery, virtual clinical trials and digital twins, patient engagement and medication adherence, as well as digitizing manufacturing, operations and much more.

Read on events.medcitynews.com

Cambridge Healthtech Institute’s Seventeenth Annual Biomarkers & Precision Oncology World Congress is the longest-running event dedicated to all areas of biomarker research and development spanning the pharmaceutical and diagnostic pipelines. Since 2004, the Congress has emerged as the leading annual meeting where big pharma and biotech drive innovation and collaboration in clinical and translational biomarkers, precision medicine and companion diagnostics, precision oncology and immuno-oncology biomarkers, liquid biopsy, spatial biology and single-cell analysis. Please join us for comprehensive scientific coverage and unparalleled networking opportunities at the in-person Biomarkers & Precision Oncology World Congress 2022 in Boston.

Read on biomarkerworldcongress.com

The 7th Annual MarketsandMarkets Biomarker and Companion Diagnostics Conference scheduled to be held on 16th - 17th June 2022 in San Diego, CA would address the gaps between early stage biomarker development and the commercialization stage of biomarkers. This conference would also highlight case studies on leveraging emerging technologies in Digital Biomarkers, Precision Medicine and Big Data. Regarding commercialization of biomarkers, leading industry and academic experts would share their case studies focusing on advancements in companion diagnostics area. The keynote presentations would also help the attendees understand the issues related to clinical translation of biomarkers.

Read on events.marketsandmarkets.com

Precision medicine is focused on the idea that a particular disease causes different physical symptoms in different individuals depending on their genome structure, lifestyle, and environmental factors.  Biomarkers are the focal point of advances in Precision Medicine. The knowledge of the genetic and genomic architecture of disorders has advanced dramatically in recent years. 

Read on magnusconferences.com

This inaugural Miami Precision Medicine Conference will highlight the best of technology, science, and oncology practice to advance the future of cancer care. CME topics will include:

• Next-Generation Sequencing, Liquid Biopsies and Molecularly Driven Clinical Trials
• Artificial Intelligence for Precision Medicine in 2022
• Facing Rare and Common Tumor Types in Adults & Children: Precision Medicine Opportunities
• New Era of Hope for Patients and Patient Advocates: Potentially Life-Saving Molecularly-Targeted Therapies

Precision medicine emerged to prominence over the last decade with a major impact on outcomes, allowing for personalized cancer treatments. The speed of scientific breakthroughs in precision medicine is leading to groundbreaking therapies. Novel Artificial Intelligence (AI) engines can potentially help to identify patterns and allow teams to uncover innovative strategies for specific cancers and individual patient populations. Today more than ever before, physician-scientists working with patients need real-time information aimed at creating an improved, value-based survivorship.

The first Miami Precision Medicine (MPM) international conference will bring together diverse experts in the field to share their knowledge and approaches in moving precision medicine towards routine practice. The course will examine the treatment landscape for various cancer types based on published and emerging data.  An interdisciplinary molecular tumor board case discussion will illustrate the role of genomic alterations in selecting targeted treatments as well as present relevant precision medicine clinical trials.

Patients and advocacy groups will have an opportunity to share their insight, learn about promising clinical trials and partner with physicians to develop new strategies tailored to their specific needs. We aim to identify barriers to precision medicine, to promote and facilitate awareness, education and equity in precision medicine cancer care.

Read on web.cvent.com

PrecisionMed Expo Dubai 2022 provides a unique opportunity for those developing personalised healthcare solutions from across the globe to do business with the key healthcare decision-makers in the Gulf and Middle East region.

Growing populations, rising life expectancy and changes in lifestyle are leaving a healthcare burden for governments in the Gulf region, they have an urgent need to find smart approaches to tackle the medical needs of their populations.

Connect with healthcare providers & laboratories, distributors, investors, research bodies & government partners to grow your presence in the fastest growing market.

Read on precisionmedexpo.com

Over the past 28 years, the Tri-Conference has served as the leading international meeting place for the precision medicine community. As the world faces the challenges from the pandemic recovery, Cambridge Healthtech Institute once again takes the leadership role of bringing together the life science community at the TRI-CON 2022. Join thousands of international thought leaders in-person and/or virtually to discuss the latest research and technologies in precision medicine and precision health; innovation in point-of-care and molecular diagnostics and market access strategies; advanced diagnostics for COVID-19 and other infectious diseases; precision oncology diagnostics and therapeutics; liquid biopsy and minimal residual disease testing; biomarkers and companion diagnostics; and new technologies for spatial multi-omic analysis. Come to sunny San Diego for the in-person networking you’ve come to expect from the Tri-Conference; or join us virtually from the comfort of your home or office for online networking, the cutting-edge scientific program, and convenient on-demand viewing.

Read on triconference.com

The Precision Medicine World Conference Silicon Valley (PMWC 2022) brings together executives and managers from Pharma and Diagnostic companies and Biotech. The Precision Medicine World Conference Silicon Valley (PMWC 2022) covers topics such as:

• 3rd Generation Sequencing
• Single-cell Proteomic Analysis
• Therapeutic Vaccines in Chronic Disease
• Evolution of Translational Omics
• Breast Cancer Genome
• Diabetes & the Quantified Self
• The role of treatment decision support in personalized cancer therapy
• WSG vs NWGS Technologies
• Implementing PM in large scale healthcare systems

Read on clocate.com

The 20th Precision Medicine World Conference (PMWC) will take place at the Pittsburgh Marriott City Center on September 23 and 24, 2021 in partnership with the University of Pittsburgh and UPMC. This city of steel has re-emerged as the city of Eds and Meds with nationally recognized universities and healthcare institutions. PMWC 2021 Pittsburgh brings together leading researchers to showcase practical content that helps close the knowledge gap among different sectors, thereby catalyzing cross-functional fertilization and collaboration to benefit both our valued partners and PMWC attendees.

Read on pmwcintl.com

Since 2009, the diagnostics community has united at Next Generation Dx Summit to discuss trendsetting developments, milestones, challenges, and opportunities in the industry. A decade later, the diagnostics industry has paved the path to the precision medicine era with the tremendous advancement in rapid and non-invasive testing, cancer detection and monitoring, and expanding applications of clinical sequencing.

This webinar showcases the innovative use of multiplexed immunofluorescence and subsequent imaging, revealing a vast potential for precision medicine: to quickly identify the right treatment for the individual patient, and limit or prevent late-stage clinical trial failures.

Read on theconferenceforum.org

The DxPx is the largest Industry & Investor Conference dedicated to companies from the diagnostics, digital health, precision medicine, and life science tool industry.

Attend the July 22 CPT® virtual meeting to discuss improving access and reducing burdens associated with genetic testing and precision medicine. Stakeholders will explore strategies to improve access and reduce the burden associated with genetic testing and precision medicine. Among other topics, strategies to evolve coding for genetic tests and what is needed beyond coding to overcome communication gaps will be discussed. 

Read on ama-assn.org